SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Creative Planning

Creative Planning increased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 15.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,114 shares of the exchange traded fund’s stock after purchasing an additional 3,920 shares during the quarter. Creative Planning’s holdings in SPDR S&P Biotech ETF were worth $2,876,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in XBI. Fifth Third Bancorp boosted its stake in shares of SPDR S&P Biotech ETF by 3.4% during the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock valued at $10,968,000 after buying an additional 3,922 shares during the period. Avantax Advisory Services Inc. raised its position in SPDR S&P Biotech ETF by 17.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock valued at $913,000 after purchasing an additional 1,415 shares during the last quarter. PFG Investments LLC increased its position in SPDR S&P Biotech ETF by 9.2% in the 2nd quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock valued at $2,303,000 after acquiring an additional 2,097 shares in the last quarter. Brookstone Capital Management bought a new position in SPDR S&P Biotech ETF in the 1st quarter valued at $284,000. Finally, Sequoia Financial Advisors LLC lifted its position in SPDR S&P Biotech ETF by 14.1% during the 1st quarter. Sequoia Financial Advisors LLC now owns 6,810 shares of the exchange traded fund’s stock valued at $646,000 after purchasing an additional 842 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.1 %

XBI stock opened at $97.15 on Friday. The company has a market cap of $7.40 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The business’s fifty day moving average is $99.14 and its 200-day moving average is $94.62.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.